Stop your crying and understand that this is a speculative stock. It will have wild gyrations and movements until there is more concrete results. What has fundamentally changed? Nothing. They have some more operating cash, Lympro is on its way and MANF news should be coming forth. They have now announced two ODD areas they are working on and have a talented group of people in key positions on their various Boards and in key positions. Do you think people like that would work with a loser? Avoid the noise. Buy on dips if you believe. IF not, hold what you have and let the plans play out.
Sentiment: Strong Buy
Figured bhuston would show up today. Silent all day yesterday with an upward movement and now lifts up its ugly head when it falls back some. Predictable basher.
First, welcome. Second, many on this board and others, myself included, have spent the time doing the homework and due diligence, including trying to understand the science as best as we can. From that work we have drawn our wn conclusions about future expectations. When someone comes to the board and puts out as their first post how many shares they own, what price they bought at etc and then starting asking for others ideas about future prices and other information it reeks of laziness and being a day trader and flipper. The better approach is to outline your expectations and plans and ask about our thoughts in response to have a dialouge. We don't get paid to give investment advice and hence would rather discuss from that aspect then just give away our work to someone who appears to be lazy and have not done their own work.
They have acquired assets which in turn have the capability to generate capital. It just takes time in the biotech sector since these are not widgets that can be built in the garage but one of the most highly regulated sectors of the economy. Prices reflect future earnings potential and not current company valuation metrics as you claim. Are those metrics part of the calculation? Yes, but they are not sole determiner, especially with biotech. And the market is not always right. Why is their alpha? Because there is price dislocation between what is fair value and what a price currently is.
I rail against people on this board for making outrageous claims in the price future of AMBS, both to the negative and positive, so people thinking that this will be $5.00 without a R/S this year are pipe dreaming. However, government contracts with regard to TBI can become a reality, especially after listening to General Chiarelli's opening remarks and his desire for collaboration.
ICPT, RNN and CBIS. Be wary of people popping up on this board trying to peddle their wares. Stick to AMBS and doing solid work because by the time the hucksters show up, the easy money has been made. Make your money here and know what is in the future.
Do you know how long it takes to submit for a grant and the process? It can be a very long and tenuous process, with multiple stages of review, selection and awards. Anyone betting on a grant being awardedless tan 6 months from when this guy was hired is a bit crazy. They just don't hand out several million dollars on a whim.
No. There will be 770 million shares outstanding once the warrants are exercised. Assuming a 400 - 500 market cap, that puts the sp at $.56 to $.70. 6 to 1 brings o/s down to 130 million shares and a price of 3.50 to 4.20. Good o/s count and lots of room to trade and create upward pressure.
There are two types of dinners in the financial world. The first is the celebratory dinner where the parties get together to reward each other and pat each other on the back after closing a deal. The second is to close deals over an expensive bottle of wine and a nice Chateau Briand with all the accoutrements. I think this is the outcome of tomorrow night.
Old news if you look at the financials. This subject and outfit has been brought up before and I have debunked it here in the past.
A buyout requires a willing party to sell when it comes to buying the whole company. Gerald et al are clearly not willing to sell. Ask yourself why sell if you don't have a product/revenue yet? Why sell if you think you can increase the value of the company through further work and then sell at a greater multiple? Why sell if you think you can control your own destiny through partnership and other funding, especially when you own a large position in the company?
As for investing in the company and buying stock, we all know why large institutions such as mutual funds et al don''t buy this right now.
Pretty simple analysis in my opinion.
Well I made well over $10,000 yesterday from the move up.